Market Place
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide. 
X
Please Wait
Applying Filters...
01 Pharmaceutical Works POLPHARMA (1)
02 Interquim, S.A. (1)
03 Dr.Reddy's Laboratories Limited (1)
04 Neuland Laboratories Limited (1)
05 Medichem Manufacturing (Malta) Ltd. (1)
06 Medichem S.A. (1)
07 Amoli Organics Private Limited (1)
08 Assia Chemical Industries Ltd - Teva Tech Site (1)
09 Aurobindo Pharma Limited (1)
10 Bayer AG (1)
11 Biocon Limited (1)
12 Cipla Ltd. (1)
13 Glenmark Life Sciences Limited (1)
14 HETERO DRUGS LIMITED (1)
15 HIKAL LIMITED (1)
16 Jubilant Pharmova Limited (1)
17 Lee Pharma Ltd. (1)
18 MSN Laboratories Private Limited (1)
19 Mylan Laboratories Limited (1)
20 Nantong Chanyoo Pharmatech Co., Ltd (1)
21 Optimus Drugs Private Limited (1)
22 Quimica Sintetica S.A. (2)
23 SYNAPTICS LABS PRIVATE LIMITED (1)
24 Shanghai Huilun Jiangsu Pharmaceutical Co., Ltd. (1)
25 Srini Pharmaceuticals Private Limited (1)
26 Symed Labs Limited (1)
27 Teva Czech Industries s.r.o (1)
28 Unichem Laboratories Limited, India (1)
29 Uquifa Mexico, S.A. de C.V. (1)
30 ZCL Chemicals Limited (1)
31 Zhejiang Huahai Pharmaceutical Co., Ltd. (1)
32 Zhejiang Supor Pharmaceuticals Co., Ltd (1)
01 RIVAROXABAN (7)
02 Rivaroxaban (23)
03 Rivaroxaban Microfine (1)
04 rivaroxaban (2)
01 China (4)
02 Germany (1)
03 India (18)
04 Israel (2)
05 Poland (1)
06 Spain (6)
07 U.S.A (1)
79
PharmaCompass offers a list of Rivaroxaban API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Rivaroxaban manufacturer or Rivaroxaban supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Rivaroxaban manufacturer or Rivaroxaban supplier.
PharmaCompass also assists you with knowing the Rivaroxaban API Price utilized in the formulation of products. Rivaroxaban API Price is not always fixed or binding as the Rivaroxaban Price is obtained through a variety of data sources. The Rivaroxaban Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Rivaroxaban manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Rivaroxaban, including repackagers and relabelers. The FDA regulates Rivaroxaban manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Rivaroxaban API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Rivaroxaban manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Rivaroxaban supplier is an individual or a company that provides Rivaroxaban active pharmaceutical ingredient (API) or Rivaroxaban finished formulations upon request. The Rivaroxaban suppliers may include Rivaroxaban API manufacturers, exporters, distributors and traders.
click here to find a list of Rivaroxaban suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Rivaroxaban as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Rivaroxaban API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Rivaroxaban as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Rivaroxaban and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Rivaroxaban NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Rivaroxaban suppliers with NDC on PharmaCompass.
We have 31 companies offering Rivaroxaban
Get in contact with the supplier of your choice:
